OncoPrecision
- Biotech or pharma, therapeutic R&D
OncoPrecision is a platform therapeutics company integrating patient-derived high-throughput biology with AI/ML to develop a pipeline of ADCs and bispecific antibodies with high PoS, focused on oncology.
Our lead program features highly selective first-in-class ADCs targeting monocytes and tumor-associated macrophages (TAMs), with a compelling preclinical package and implications across a broad range of diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}